The Diagnostic Biomarkers Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Diagnostic Biomarkers Market?
The size of the diagnostic biomarkers market has seen swift expansion in recent years. The market is predicted to increase from $65.25 billion in 2024 to $75.67 billion in 2025, with a compound annual growth rate (CAGR) of 16.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Diagnostic Biomarkers Industry?
The Diagnostic Biomarkers Global Market is predicted to grow to $136.57 billion in 2029, with a compound annual growth rate (CAGR) of 15.9%.
Download Your Free Sample of the 2025 Diagnostic Biomarkers Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Diagnostic Biomarkers Market?
The key drivers in the diagnostic biomarkers market are:
• Rising adoption of liquid biopsy techniques
• Increasing financial investment in biomarker research
• Heightened focus on precision medicine
• Expanding applications of biomarkers in neurodegenerative diseases
Global Market Segmentation: Identifying Major Diagnostic Biomarkers Industry Segments
The diagnostic biomarkers market covered in this report is segmented –
1) By Product: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Application: Oncology, Metabolic Disease, Neurological Disease
3) By End User: Hospitals, Cancer Research Institutes, Diagnostic Labs
Subsegments:
1) By Safety Biomarkers: Toxicity Biomarkers, Organ-Specific Safety Biomarkers, Drug-Induced Injury Biomarkers
2) By Efficacy Biomarkers: Predictive Biomarkers, Prognostic Biomarkers, Pharmacodynamic Biomarkers
3) By Validation Biomarkers: Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers
Pre-order the 2025 Diagnostic Biomarkers Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Diagnostic Biomarkers Market?
The key trends in the diagnostic biomarkers market are:
• Advancements in artificial intelligence and machine learning are impacting the future of the diagnostic biomarkers market.
• The integration of multi-omics approaches is a significant emerging trend.
• The development and use of point-of-care diagnostic tools are increasingly shaping the industry.
• The market is being influenced by a shift towards digital biomarkers and the widespread use of wearable health monitoring devices.
Who Are the Top Competitors & Leading Players in the Diagnostic Biomarkers Market?
Major players in the diagnostic biomarkers market are:
• Johnson & Johnson Services Inc.
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• PerkinElmer Inc.
• Siemens Healthineers AG
• Merck KGaA
• Agilent Technologies Inc.
• Charles River Laboratories International Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Qiagen N.V.
• Myriad Genetics Inc.
• Meso Scale Diagnostics LLC
• EKF Diagnostics Holdings Plc
• Sino Biological Inc.
• Enzo Biochem Inc.
• Biomarker Technologies Inc.
• Cisbio Bioassays
• Signosis Inc.
• Epigenomics AG
• LifeSign LLC
• Banyan Biomarkers Inc.
• Biosims Technologies SAS
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the diagnostic biomarkers market in 2024
